שווי כולל של החברה: Turnstone Biologics Corp. (TSBX)

Turnstone Biologics is developing scientific partnerships with medical centers to create tumor-fighting methods by activating the body's own lymphocytes. The asset's market dynamics reflect an Enterprise Value of . The business valuation is supported by unique cell-selection patents that create a closed supply network, while management is strictly optimizing R&D costs to increase liquidity reserves.

Turnstone Biologics' unique patents for growing immune cells create significant intrinsic business value, which is reflected in the current value of . By analyzing the EV chart, an investor can see the total acquisition cost of the asset, summing market capitalization and net debt, which allows for an objective assessment of capital structure stability and debt load risks without time lags.